| For: | Chidambaram D, Subashini V, Nanthanalaxmi M, Saranya I, Selvamurugan N. Regulation of matrix metalloproteinase-13 in cancer: Signaling pathways and non-coding RNAs in tumor progression and therapeutic targeting. World J Clin Oncol 2025; 16(6): 105996 [PMID: 40585828 DOI: 10.5306/wjco.v16.i6.105996] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i6/105996.htm |
| Number | Citing Articles |
| 1 |
Suqin Xu, Xianping Liu, Chenglu Huang. Cumulative evidence for associations between matrix metalloproteinase‑1, ‑3 and ‑8 variants and cancer risk. Oncology Letters 2026; 32(1) doi: 10.3892/ol.2026.15640
|
| 2 |
Septika Prismasari, Hyeong Jae Kim, Jeong Hee Hong, Jung Yun Kang. Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity. Pharmaceutics 2026; 18(5) doi: 10.3390/pharmaceutics18050622
|
| 3 |
Joaquim Faria Monteiro, Alexandrina Fernandes, Diogo Gavina Tato, Elias Moreira, Ricardo Ribeiro, Henrique Reguengo, Jorge Gonçalves, Paula Fresco. Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers 2025; 17(19) doi: 10.3390/cancers17193262
|
| 4 |
Evangelia Krikou, Ioanna A. Anastasiou, Panagiotis Sarantis, Hariklia Gakiopoulou, Irini Theochari, Dimitra Grigoriadou, Andreas C. Lazaris, Eleftheria Lakiotaki. Advances in Extracellular Matrix Metalloproteinases: Implications for Renal Cell Carcinoma Pathophysiology, Diagnostics, and Therapeutics. Medicines 2026; 13(1) doi: 10.3390/medicines13010009
|
| 5 |
Yimao Wu, Zichang Chen, Xiaoyan Chen, Yinting Hu, Yunqi Ma. Recent advances in the investigation of the regulatory network underlying reactive nitrogen species-mediated tumorigenesis: molecular mechanisms and targeted therapeutic strategies. Redox Report 2025; 30(1) doi: 10.1080/13510002.2025.2564593
|
| 6 |
Sendegul Yildirim, Momoka Nagamine, Myoung Hwan Kim, Amanda Becceneri, Nazmiye Celik, Ilayda Namli, Todd M Umstead, Zissis C Chroneos, Gamze Tanriover, Ibrahim T Ozbolat. Therapeutic potential of TAS-115 in 3D breast cancer models. Biofabrication 2026; 18(1) doi: 10.1088/1758-5090/ae2400
|
| 7 |
Zachery R. Robinson, Sabrina C. Fong, Daniella Y. Choi, Sophia Siopack, Alexander Bolanos-Campos, Negar Morshedian, Eva Utke, Mayuka Ninomiya Kanda, Cameron Kato, Michael J. Conboy, Irina M. Conboy. Selective targeting of cancer and senescence via shared metabolic shifts extends lifespan of old mice. Aging 2026; 18(1) doi: 10.18632/aging.206399
|